Become a Member

written by reader Anyone have additional DD on $RVVTF (Revive Therapeutics) repurposing of Bucillamine (anti-rheumatic) for COVID treatment?

By Baron, March 22, 2022

Hi folks. Disclaimer, I currently have a position in $RVVTF but I’m looking to bolster my research before perhaps taking a larger position. I know the FDA let Revive SKIP Phase II and go straight to Phase III trials but I’m not well-versed in the science behind this. I rely on folks in the biotech field and would appreciate someone like Doc Gumshoe or the sleuths here on GumShoe to kick the tires, weigh in…

Thanks in advance.
Baron

https://www.nasdaq.com/articles/revive-gets-clearance-in-turkey-to-proceed-with-phase-3-trial-for-bucillamine-in-covid-19

Revive Therapeutics – DD Compendium (updated) from RVVTF

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.

guest

12345

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Inline Feedbacks
View all comments

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info  
14
0
Would love your thoughts, please comment.x
()
x